A 3-arm study sought to compare the effects of homeopathic treatments on quality of life with placebo, and survival time with placebo or no treatment.
Approval is for tremelimumab in combination with durvalumab and platinum-based chemotherapy.
A prospective study compared aprepitant with desloratadine for the relief of treatment-induced pruritus in patients with lung cancer treated with EGFR-TKIs.
Investigators characterized the toxicity of stereotactic body radiotherapy for oligometastases from predominantly prostate, colorectal, breast, and lung cancer.
A review of lung cancer in men and women described the sex-associated differences in risks, prognosis, and care of patients with the disease.